Select Language
Chinese (Simplified)
Chinese (Traditional)
English
French
German
Japanese
Korean
Spanish
HOME
新聞
服務
訂閱
廠商
EN
關於
下載 APP
聯絡
查看購物車
請選擇單元
每日新聞
市場分析
生醫人物
創新創業
展會直擊
雜誌報導
出版品
搜尋
會員登入
註冊
生醫新聞
每日新聞
生技醫藥
醫療科技
再生醫學/細胞治療
科學新知
政策法規
應用生技
論壇報導
新聞集錦
GBI International
商情中心
產業分析
公司重訊
漲跌排名
生醫永續
查找廠商
焦點人物
生醫人物
人物專訪
國際報導
專家觀點
生醫名人錄【影】
編輯專欄
創業投資
新創動態
投募專區
生醫攬才
【影】技術焦點鏡
展會直擊
論壇報導總覽
北美生物科技產業展(BIO) 2025
亞洲生技大會(BIO Asia–Taiwan) 2025
台灣國際醫療暨健康照護展(Medical Taiwan) 2025
美國臨床腫瘤醫學會年會(ASCO) 2025
日本生技展
德國醫療器材展(MEDICA)
台灣醫療科技展(Healthcare+)
摩根大通醫療健康年會(JPM)
生技產業策略諮議會議(BTC)
產業論壇
海外展會
Podcast
雜誌專題
各期專題列表|雜誌線上看
2025臺灣生醫女掌門人 Top10票選出爐
太陽西邊升起 印度生醫
迎戰阿茲海默症?臺灣療法/檢測勇闖創新賽道
「失眠經濟」未來10年大翻5倍!
2024臺灣生技醫藥精彩表現總回顧
RNA核酸藥品掀狂熱 引領10年藥物大未來⁈
「創新手術室」MIT大艦隊
購買出版品
編輯部公告
產業活動
活動列表
活動快訊
亞洲生技大會快訊
新聞
GBI International
GBI International
NEW
Pioneering Non-Viral CAR-T in Asia – Dr. Yozo Nakazawa's Mission
GBI International
NEW
The sun rises in the West — Welcome to the era of India Biotech!
GBI International
NEW
Movement has no age limit — and rehab should be smarter too!
GBI International
GBIHighlights
BRIM Biotechnology, Inc. announced its three focus areas for this year's operations
2024-02-28/
GlobalBio & Investment
#OphthalmologyInnovationGreatnewsfromBRIMBiotechnology,Inc.(6885.TWO)!Thecompanyhasannounceditsthreefocusareasforthisyear'soperations,whichinclude:1.ContinuingthedevelopmentofBRM421,theirleadasset...
GBI International
GBIHighlights
Sartorius experts highlighted the key specifications of the new PIC/S GMP Annex 1 regulation
2024-02-28/
GlobalBio & Investment
#BiotechInsightsExcitingupdatesfromSartoriusandAdimmuneCorp(4142)'scorporateseminar!Sartoriusexperts,Tse-WeiChenandRZLin,highlightedthelatesttrendsincellculturedevelopmentandthekeyspecificationsof...
GBI International
GBIHighlights
AnHorn partnered with European startups to explore new treatment targets for prostate cancer
2024-02-28/
GlobalBio & Investment
#InnovativeCollaborationAnHornMedicines,anAI-drivendrugdiscoverycompanyfocusedonproteindegradation,haspartneredwithEuropeanstartupstoexplorenewtreatmenttargetsforprostatecancer.On20February2024,Anhorn...
GBI International
GBIHighlights
PharmaEssentia and Oneness Biotech Co Ltd have been honored in Sustainability Yearbook 2024
2024-02-28/
GlobalBio & Investment
#ESGExcellenceExcitingnews!PharmaEssentia(TPE:6446)andOnenessBiotechCoLtd(TPE:4743)havebeenhonoredintheprestigiousSustainabilityYearbook2024byS&PGlobalRatings.PharmaEssentiamarksahistoricmomentast...
GBI International
GBIHighlights
How does medical technology revolutionize commercial health insurance?
2024-02-28/
GlobalBio & Investment
#MedicalInsuranceDidyouknowthattheaveragepersoninTaiwanhasthreeinsurancepolicies?Withtheriseofemergingmedicaltechnology,commercialhealthinsuranceisbeingrevolutionized.In2023,theBio-TaiwanCommittee(#BT...
GBI International
GBIHighlights
Leadgene Biomedical, Inc.'s LEADGENE® IS ELISA Kit has been approved by Taiwan's FDA...
2024-02-28/
GlobalBio & Investment
#TFDAApprovalExcitingnews!LeadgeneBiomedical,Inc.'sLEADGENE®IndoxylSulfate(IS)ELISAKit,aCE-markedprotein-boundtoxindiagnosiskit,hasbeenapprovedbyTaiwan'sFDAasaClassIIIinvitrodiagnosticdevi...
GBI International
GBIHighlights
Nine biopharma companies have announced record-high revenues for January
2024-02-28/
GlobalBio & Investment
#BiotechGrowthExcitingnewsfromthe#biopharmasector!Ninebiopharmacompanieshaveannouncedrecord-highrevenuesforJanuary,indicatingaprosperousstarttotheyear.Amongthem,AnxoPharmaceuticalTaiwanCo.Ltd(6677.TWO...
GBI International
GBIHighlights
FDA approves Onivyde® as a first-line therapy for metastatic pancreatic adenocarcinoma
2024-02-28/
GlobalBio & Investment
**#FDAApproval**ExcitingnewsforPharmaEngineInc(4162.TWO)!FDAapproves#Onivyde®asafirst-linetherapyformetastaticpancreaticadenocarcinoma,markingapotentialnewstandardofcare.PharmaEngine'scollabor...
GBI International
GBIHighlights
The potential of next-generation microbiome therapy in clinical applications (8th AMC)
2024-02-28/
GlobalBio & Investment
*#MicrobiomeTherapy**Canthegutmicrobiotarevolutionizecancertreatment?Insightsfromthe8thAsiaMicrobiomeConference(#AMC),heldbyIBCAcademiaSinica,NationalTaiwanUniversityHospital,and圖爾思生物科技BIOTOOLSCO.,LTD...
GBI International
GBIHighlights
Chang Gung Medical Foundation teams up with Gilead Sciences to accelerate early-stage clinical trial
2024-02-28/
GlobalBio & Investment
**#ClinicalTrials**ChangGungMedicalFoundationteamsupwithGileadSciencestoaccelerateearly-stageclinicaltrials,focusingon#oncology.Thecollaborationaimstoadvanceclinicaltrialsintumorresearch,preclinicalco...
GBI International
GBIHighlights
GBI Spotlight: Dr. Han-Chung Wu
2024-02-28/
GlobalBio & Investment
#GBISpotlight:Dr.Han-ChungWu(吳漢忠)MeetDr.Han-ChungWu,themanbehindthedevelopmentofprecisiontherapythroughinnovativephagedisplaytechnology.AstheDirectorofBioTrecatNBRP,AcademiaSinica,heisawell-knownfigur...
GBI International
GBIHighlights
Meet David Lee, the visionary founder and CEO of Singular Wings Medical
2024-02-28/
GlobalBio & Investment
**#Meet#StartupCEOs**MeetDavidLee(李維中),thevisionaryfounderandCEOofSingularWingsMedical.Fromtheelectronicsindustrytoentrepreneurship,hemerges#healthcarewith#electronics,craftinginnovativesolutionsforme...
第一頁
上一頁
10
11
12
13
14
下一頁
最後頁
當期雜誌
查看更多
2025臺灣生醫女掌門人 Top10票選出爐
記者列表
查看更多
記者 彭梓涵
記者 王柏豪
記者 吳培安
記者 李林璦
記者 鄔麗.巴旺
實習記者 康育華
影音專區
查看更多
【影音】臺灣生醫新創CEOs高峰會 百位CEO齊聚!
展會直擊
查看更多
韓國連二年奪地主國外最大參展國 CDMO佔據強勢地位
泰合生技公布抗血栓口溶膜樞紐試驗數據
奈捷失智超高靈敏度血檢、NGS白血病精準醫療落地美國
康霈發布「改善復胖」臨床前成果 Q4送FDA臨床二期IND
精拓生技E.V.A.類器官平台登場!少量血液打造癌症測藥替身